SCTX stock news

SCTX stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

14 wire items

2026-09-02 20:21:55 UTC#258453updateconfirmednews

Scribe Therapeutics Q2 GAAP EPS -$2.62 beats by $1.15, revenue $1.92M misses by $1.19M

seeking alphaimportance 0.40trust 0.80Scribe Therapeutics Inc. +0.20

2026-09-02 20:10:58 UTC#258469duplicateconfirmednews

Scribe Therapeutics reports Q2 2026 net loss of $6.5M, initiates STX-1150 Phase 1 trial

quartrimportance 0.40trust 0.70Scribe Therapeutics Inc. +0.50STX-1150 +0.40California Institute for Regenerative Medicine +0.30

2026-07-27 10:09:00 UTC#81032newconfirmednews

Scribe Therapeutics files for $128.7M Nasdaq IPO at $15/share with Sanofi private placement

tradingviewimportance 0.50trust 0.80Scribe Therapeutics, Inc. +0.30Sanofi +0.30Nasdaq, Inc. 0

2026-07-24 21:20:11 UTC#77136duplicateconfirmednews

Scribe Therapeutics shares surge 67% in Nasdaq debut following $128.7 million IPO

bloombergimportance 0.30trust 0.90Scribe Therapeutics, Inc. +0.60

2026-07-24 18:45:19 UTC#76569updateconfirmednews

Scribe Therapeutics Shares Surge 67% to $25 in Nasdaq Debut Following $128.7M Upsized IPO

yahooimportance 0.50trust 0.70Scribe Therapeutics, Inc. +0.60Sanofi SA +0.30Alameda 0+1 entities

2026-07-24 17:35:45 UTC#76322duplicateconfirmednews

Scribe Therapeutics shares surge in Nasdaq debut following $128.7M IPO

seeking alphaimportance 0.30trust 0.70Scribe Therapeutics, Inc. +0.60Eli Lilly and Company +0.20Sanofi +0.20

2026-07-24 17:35:45 UTC#76321updateconfirmednews

Scribe Therapeutics shares surge in Nasdaq debut following $128.7M IPO

seeking alphaimportance 0.40trust 0.70Scribe Therapeutics, Inc. +0.50Eli Lilly and Company +0.20Sanofi +0.20

2026-07-24 09:58:00 UTC#74154duplicateconfirmednews

Scribe Therapeutics IPO Prices at $15 Per Share, Raising $128.7 Million

dow_jonesimportance 0.30trust 0.90Scribe Therapeutics, Inc. +0.30Nasdaq, Inc. 0

2026-07-24 04:20:08 UTC#73065duplicateconfirmednews

Scribe Therapeutics raises $128.7 million in upsized IPO priced at top of range

bloombergimportance 0.30trust 0.90Scribe Therapeutics, Inc. +0.40

2026-07-24 04:06:39 UTC#73056duplicateconfirmednews

Scribe Therapeutics Raises $128.7M in Upsized IPO, Set to Begin Trading on Nasdaq

seeking alphaimportance 0.30trust 0.80Scribe Therapeutics, Inc. +0.40Eli Lilly and Company +0.20Nasdaq, Inc. +0.10

2026-07-24 01:10:18 UTC#72718newconfirmedpress release

Scribe Therapeutics prices upsized IPO of 8.58 million shares at $15 per share

reutersimportance 0.50trust 0.90Scribe Therapeutics Inc. +0.20

2026-07-20 15:50:11 UTC#53292duplicateconfirmednews

Scribe Therapeutics seeks up to $107.2 million in US IPO

bloombergimportance 0.30trust 0.90Scribe Therapeutics, Inc. +0.20

2026-07-20 11:58:00 UTC#52149newconfirmednews

Scribe Therapeutics sets IPO for 7.15 million shares at $13-$15 range, with Sanofi private placement

dow_jonesimportance 0.50trust 0.90Scribe Therapeutics, Inc. +0.30Sanofi S.A. +0.20Eli Lilly and Company +0.20

2026-07-15 18:38:08 UTC#37272newreportednews

Braveheart, Attovia, Apnimed, and Scribe Therapeutics join July biotech IPO rush, Seeking Alpha reports

seeking alphaimportance 0.40trust 0.60Braveheart Investment Group plc +0.20Attovia Therapeutics, Inc. +0.20Apnimed, Inc. +0.20+1 entities